4.6 Article

Measurement of MRI scanner performance with the ADNI phantom

期刊

MEDICAL PHYSICS
卷 36, 期 6, 页码 2193-2205

出版社

WILEY
DOI: 10.1118/1.3116776

关键词

biomedical MRI; diseases; neurophysiology; phantoms

资金

  1. Alzheimer's Disease Neuroimaging Initiative [U01 AG024904]
  2. National Institute of Aging
  3. National Institute of Biomedical Imaging and Bioengineering (NIBIB)
  4. Foundation for the National Institutes of Health
  5. National Institute of Aging [R01 AG11378]
  6. NIH [C06 RR018898, AG11378]

向作者/读者索取更多资源

The objectives of this study are as follows: to describe practical implementation challenges of multisite, multivendor quantitative studies; to describe the MRI phantom and analysis software used in the Alzheimer's Disease Neuroimaging Initiative (ADNI) study, illustrate the utility of the system for measuring scanner performance, the ability to assess gradient field nonlinearity corrections: and to recover human brain images without geometric scaling errors in multisite studies. ADNI is a large multicenter study with each center having its own copy of the phantom. The design of the phantom and analysis software are presented as results from predistribution systematics studies and results from field experience with the phantom at 58 enrolling ADNI sites over a 3 year period. The estimated coefficients of variation intrinsic to measurements of geometry in a single phantom are in the range of 3-5 parts in 10(4). Phantom measurements accurately detect linear and nonlinear scaling in images. Gradient unwarping methods are readily assessed by phantom nonlinearity measurements. Phantom-based scaling correction reduces observed geometric drift in human images by one-third or more. Repair or replacement of phantoms between scans, however, is a confounding factor. The ADNI phantom can be used to assess both scanner performance and the validity of postprocessing image corrections in order to reduce systematic errors in human images. Reduced measurement errors should decrease measurement bias and increase statistical power for measurements of rates of change in the brain structure in AD treatment trials. Perhaps the greatest practical value of incorporating ADNI phantom measurements in a multisite study is to identify scanner errors through central monitoring. This approach has resulted in identification of system errors including sites misidentification of their own gradient hardware and the disabling of autoshim, and a miscalibrated laser alignment light. If undetected, these errors would have contributed to imprecision in quantitative metrics at over 25% of all enrolling ADNI sites.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据